YUTREPIA: A New FDA Approved Treatment for PAH & PH-ILD
I’m Aware That I’m Rare: the phaware® podcast
Episode 523 - Rodolfo Estrada, MD
Dr. Rodolfo Estrada, is a seasoned pulmonologists currently at UT Health San Antonio with significant experience in the management of patients with different forms of pulmonary hypertension. In this episode Dr. Estrada will discuss the technology and clinical development behind YUTREPIA™ (treprostinil) inhalation powder and why it might be a good option for some PAH and PH-ILD patients.
Clinical Trials: Pushing the Field Forward in PH-ILD
I’m Aware That I’m Rare: the phaware® podcast
Episode 521 - Jean Elwing, MD
Dr. Jean Elwing, a leading expert in pulmonary hypertension, discusses groundbreaking advancements in treating pulmonary hypertension associated with interstitial lung disease (PH-ILD). For years, patients with this condition had limited treatment options beyond oxygen therapy and symptom management. However, recent studies have introduced new hope, showing improved patient outcomes and quality of life. Dr. Elwing emphasizes the importance of early diagnosis, ongoing research, and clinical trial participation in pushing the field forward.
The Evolution of Inhaled Therapies: PRINT® Technology
I’m Aware That I’m Rare: the phaware® podcast
Episode 520 - Seth Hall, MBA, RRT
Seth Hall, MBA, RRT, takes listeners on a journey through the past, present, and future of inhaled therapies. Discover how these treatments have evolved, the life-changing benefits they offer, and the revolutionary technologies that could redefine outcomes for PAH and PH-ILD patients.
PH-ILD Breakthroughs: New Therapies Changing Lives
I’m Aware That I’m Rare: the phaware® podcast
Episode 519 - Richard Channick, MD
Dr. Richard Channick, dives into the evolving world within pulmonary hypertension - interstitial lung disease (PH-ILD). He sheds light on why early diagnosis matters and how new therapies are transforming care. Learn about the latest FDA-approved treatment and what’s on the horizon.